European Journal of Dermatology


Treatment with injectable platelet-rich fibrin in a rat model of melasma Volume 33, numéro 5, September-October 2023

Figure 1.

Direct products obtained after centrifugation for blood collection.

Figure 2.

Separation of IPRF.

Figure 3.

Appearance of back skin in the healthy group (L) and modelling group (R).

Figure 4.

Immunostaining of the UVB-free group (L) and UVB-applied group (R).

Figure 5.

Skin of the control group (L) and treatment group (R).

Figure 6.

Immunostaining of control group (L) and treatment group (R).